ASH Clinical Research Training Institute (CRTI) in Latin America Grant

The ASH Clinical Research Training Institute (CRTI) in Latin America is a two-day workshop designed for hematology professionals in Latin America. It aims to enhance clinical trial design skills, foster networking, and provide mentorship for project development. Participants will gain essential skills for patient-oriented research and receive support for their capstone projects. Travel and housing costs for attendees are covered by ASH, making this an invaluable opportunity for early-career clinicians.

The ASH Clinical Research Training Institute (CRTI) in Latin America is a two-day highly-interactive in-person workshop intended for fellows and early- to mid-career hematology faculty working in Latin American countries to become more familiar with clinical trial design and execution. As a participant, you will:
Build a foundation and explore the methodologies of patient-oriented clinical research.Strengthen fundamental skills needed to become a successful patient-oriented clinical leader.Gain extensive networking opportunities with others who share the same passion.Develop a potential capstone project that builds upon skills learned during the curriculum and small group peer-reviews.Receive individualized mentorship from program faculty to advance your proposed project.
Participants’ housing and travel expenses to attend the workshop will be covered by ASH.

Eligibility

Be a clinician (medical doctor, nurse, psychologist, etc.) with a clinical practice in benign or malignant hematology. Be a fellow or have a current faculty appointment within 15 years from the first faculty appointment in a division or department of hematology or oncology in Latin America.Be fluent in written and spoken English.Be a physician actively working in one of the following countries:ArgentinaBoliviaBrazilChileColombiaCosta RicaCubaDominican RepublicEcuadorEl SalvadorGuatemalaHondurasMexicoNicaraguaPanamaParaguayPeruUruguayVenezuela

Ineligibility

Please note that a clinical practice exclusively in solid tumors and research interests focused exclusively on laboratory-based research are not sufficient to qualify.